InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Segal Lloyd Mitchell, 董事长兼首席执行官. Officer active across 2 companies, notably Repare Therapeutics Inc.. Aggregated, 12 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €470k. History available since 18 May 2021. The latest transaction was disclosed on 12 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Segal Lloyd Mitchell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
19,631 股Common StockSEC:0001193125-26-010575:0
21,179 股@ US$1.142.5% 占其流量Common SharesSEC:0001415889-25-008105:0
40,000 股0Common SharesSEC:0001415889-25-007239:0
2,650 股@ US$4.621.3% 占其流量Common SharesSEC:0001415889-24-009629:0
2,650 股@ US$4.791.3% 占其流量Common SharesSEC:0001415889-24-009249:0
40,000 股0Common SharesSEC:0001415889-24-006464:0
78,550 股0Common SharesSEC:0001209191-23-006062:0
1,542 股@ US$35.619.8% 占其流量Common StockSEC:0001209191-21-044032:0
1,576 股@ US$35.009.6% 占其流量Common StockSEC:0001209191-21-039621:0
6,648 股@ US$31.7437.0% 占其流量Common StockSEC:0001209191-21-038747:0
3,770 股@ US$35.030623.0% 占其流量Common StockSEC:0001209191-21-034874:0
1,800 股@ US$35.0011.0% 占其流量Common StockSEC:0001209191-21-034571:0
12 条申报中的 12 条
About Segal Lloyd Mitchell
Lloyd Mitchell Segal is the President and CEO of Repare Therapeutics Inc. He leads the company in its efforts to develop innovative therapies in the biotechnology field.
